Laboratory News and Research

RSS

Epidural electrical stimulation stabilizes blood pressure in patients suffering from spinal cord injury

An implant that delivers electrical stimulation to a select group of spinal neurons can treat dangerously low blood pressure in people with spinal cord injuries, addressing an often "invisible" consequence of paralysis.

7 Apr 2023

Ingenious device enables construction of complex 3D organoids in a simpler way

A team led by Masaya Hagiwara of RIKEN national science institute in Japan has developed an ingenious device, using layers of hydrogels in a cube-like structure, that allows researchers to construct complex 3D organoids without using elaborate techniques.

7 Apr 2023

Broccoli intake protects the small intestine lining, inhibits development of disease

Broccoli is known to be beneficial to our health. For example, research has shown that increased consumption of the cruciferous vegetable decreases incidences of cancer and type 2 diabetes.

6 Apr 2023

Creation of embryo-like structures from monkey embryonic stem cells for the first time

Human embryo development and early organ formation remain largely unexplored due to ethical issues surrounding the use of embryos for research as well as limited availability of materials to study.

6 Apr 2023

Injectable microtissue shows promise to improve neuromuscular recovery after peripheral nerve injuries

Researchers engineered the first injectable microtissue containing motor and sensory neurons encased in protective tissue, called tissue engineered neuromuscular interfaces (TE-NMIs).

6 Apr 2023

Combinatorial biomarker predicts response to immunotherapy in kidney cancer patients

The number of immune cells in and around kidney tumors, the amount of dead cancer tissue, and mutations to a tumor suppressor gene called PBRM1 form a biomarker signature that can predict — before treatment begins — how well patients with kidney cancer will respond to immunotherapy, according to new research directed by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Air pollution associated with increased risk of developing dementia

Exposure to fine particulate air pollutants (PM2.5) may increase the risk of developing dementia, according to a new meta-analysis from Harvard T.H. Chan School of Public Health.

6 Apr 2023

How does increased family mealtime duration affect children's fruit and vegetable intake?

Researchers evaluated the effect of extending the family mealtime duration on fruit and vegetable intake in children.

6 Apr 2023

Seda: Winners of Bionow Business Growth Award 2022

Seda are honoured to have been named winners of the Business Growth Award at the prestigious Bionow Awards 2022. This award recognises our outstanding growth, innovation, and contribution to the North of England’s life sciences sector, as well as our commitment to innovation and excellence in the pharmaceutical industry.

From Seda Pharmaceutical Development Services 6 Apr 2023

Using brain organoids to test gene therapies for a rare disease in children

Brain tissue grown in a laboratory by University of Queensland researchers will be used to test a treatment for a rare disease in children and help unlock therapies for a range of neurological disorders.

5 Apr 2023

Scientists receive federal funding to model the emergence and spread of biological threats

Modeling the emergence and spread of biological threats isn't as routine as forecasting the weather, but scientists in two of the U.S. Department of Energy's national laboratories were awarded funding to try to make it so.

5 Apr 2023

Complex assembly process involved in DNA virus replication revealed

In a twist on the question, "Which came first, the chicken or the egg?", scientists have long faced a similar question about how human adenovirus replicates: "Which comes first, assembly of the viral particle, or packaging of the viral genome?"

5 Apr 2023

Key molecular pathway for organ damage in COVID patients discovered

Even after three years since the emergence of COVID-19, much remains unknown about how it causes severe disease, including the widespread organ damage beyond just the lungs.

5 Apr 2023

Scientists unearth some of the biological mechanisms behind ferroptosis

A team of researchers at Tohoku University has unearthed some of the biological mechanisms of ferroptosis, a recently discovered type of regulated cell death that is triggered by iron and the accumulation of lipid peroxidation - lipids that have undergone oxidative degeneration.

5 Apr 2023

Biological underpinnings of a reproductive disorder caused by mutation of autism gene

A University of California, Riverside, study has identified the biological underpinnings of a reproductive disorder caused by the mutation of a gene.

5 Apr 2023

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Mosaic Therapeutics, an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, today announced the close of its $28 million series A funding round.

From Mosaic Therapeutics 4 Apr 2023

Social isolation linked to higher levels of tiredness

In a study conducted in the lab as well as during the COVID-19 lockdowns, participants reported higher levels of tiredness after eight hours of social isolation. The results suggest that low energy may be a basic human response to a lack of social contact.

4 Apr 2023

Shape-shifting antibiotics may be the new weapon against drug-resistant superbugs

In the United States alone, drug-resistant bacteria and fungi infect almost 3 million people per year and kill about 35,000. Antibiotics are essential and effective, but in recent years overuse has led to some bacteria developing resistance to them.

4 Apr 2023

Getting sick often may increase the risk of dementia

Getting sick often may impact how quickly the brain ages and increase the risk of dementia or other forms of cognitive decline.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

Laboratory News and Research

Epidural electrical stimulation stabilizes blood pressure in patients suffering from spinal cord injury

Ingenious device enables construction of complex 3D organoids in a simpler way

Broccoli intake protects the small intestine lining, inhibits development of disease

Creation of embryo-like structures from monkey embryonic stem cells for the first time

Injectable microtissue shows promise to improve neuromuscular recovery after peripheral nerve injuries

Combinatorial biomarker predicts response to immunotherapy in kidney cancer patients

Air pollution associated with increased risk of developing dementia

How does increased family mealtime duration affect children's fruit and vegetable intake?

Seda: Winners of Bionow Business Growth Award 2022

Using brain organoids to test gene therapies for a rare disease in children

Scientists receive federal funding to model the emergence and spread of biological threats

Complex assembly process involved in DNA virus replication revealed

Key molecular pathway for organ damage in COVID patients discovered

Scientists unearth some of the biological mechanisms behind ferroptosis

Biological underpinnings of a reproductive disorder caused by mutation of autism gene

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Social isolation linked to higher levels of tiredness

Shape-shifting antibiotics may be the new weapon against drug-resistant superbugs

Getting sick often may increase the risk of dementia

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Lab Diagnostics and Automation - Second Edition eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News